Clinical Trials in Portland

Showing 1861-1880 of 8,670 trials

A Patient Registry Study for Patients Treated With Voretigene Neparvovec in US

NCT03597399

The objective of this study is to collect long-term safety information (i.e., for 5 years after treatment) associated with voretigene neparvovec-rzyl (vector and/or transgene), its subretinal injection procedure, the concomitant use of corticosteroids, or a combination of these procedures and products. The enrollment period will last for two years from the first treatment following product approval (through 31March2020) and include a minimum of 40 patients.

Confirmed Biallelic RPE65 Mutation-associated Retinal Dystrophy

Spark Therapeutics, Inc.87 participantsStarted Jan 2019

Los Angeles, California, United States • Miami, Florida, United States • Iowa City, Iowa, United States +7 more locations

Active Not RecruitingPhase 3< 1 mile

Assessing Compliance With Mercaptopurine Treatment in Younger Patients With Acute Lymphoblastic Leukemia in First Remission

NCT01503632

This randomized phase III trial studies compliance to a mercaptopurine treatment intervention compared to standard of care in younger patients with acute lymphoblastic leukemia that has had a decrease in or disappearance of signs and symptoms of cancer (remission). Assessing ways to help patients who have acute lymphoblastic leukemia to take their medications as prescribed may help them in taking their medications more consistently and may improve treatment outcomes.

Acute Lymphoblastic Leukemia

Children's Oncology Group570 participantsStarted Feb 2012

Birmingham, Alabama, United States • Birmingham, Alabama, United States • Downey, California, United States +99 more locations

A Patient Registry Study for Patients Treated With Voretigene Neparvovec in US

Assessing Compliance With Mercaptopurine Treatment in Younger Patients With Acute Lymphoblastic Leukemia in First Remission

Find Trials by Condition in Portland

Nodify XL2 Classifier Clinical Utility Study in Low to Moderate Risk Lung Nodules

Clinical Procedures to Support Research in ALS

Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice and Pembrolizumab in Patients With Previously Untreated, Locally Advanced Inoperable or Metastatic Triple-Negative Breast Cancer

EASE: The Materna Prep Pivotal Study

An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease

The Use of Mentoring to Promote Well-being for Female SMART Members

Promising ROd-cone DYstrophy Gene therapY

Clinical Effectiveness Assessment of VeriStrat® Testing and Validation of Immunotherapy Tests in NSCLC Subjects

A Study of Orforglipron (LY3502970) Compared With Semaglutide in Participants With Type 2 Diabetes Inadequately Controlled With Metformin

Efficacy & Safety Study of Pregabalin to Treat Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS)

Short-course Regimens for the Treatment of Pulmonary Tuberculosis

Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease

Dexmedetomidine in the Treatment of Agitation Associated With Schizophrenia and Bipolar Disorder (SERENITY III)

SUNSET: SBRT for Ultra-central NSCLC- a Safety and Efficacy Trial

Health Education Materials With/Out a Physical Activity Program for Patients Who Have Undergone Treatment for High-Risk Stage II or Stage III Colon Cancer

PRO 140 in Treatment-Experienced HIV-1 Subjects

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of VYN201 Gel in Subjects With Non-segmental Vitiligo.

A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease